These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 39197297)
21. Pharmacotherapy of insomnia: practice and prospects. Dingemanse J Pharm World Sci; 1995 May; 17(3):67-75. PubMed ID: 7550052 [TBL] [Abstract][Full Text] [Related]
22. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study. Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351 [TBL] [Abstract][Full Text] [Related]
23. Long-term use of hypnotics: Analysis of trends and risk factors. Enomoto M; Kitamura S; Tachimori H; Takeshima M; Mishima K Gen Hosp Psychiatry; 2020; 62():49-55. PubMed ID: 31786448 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study. Inoue Y; Takaesu Y; Koebis M BMC Psychiatry; 2021 Apr; 21(1):193. PubMed ID: 33853571 [TBL] [Abstract][Full Text] [Related]
25. Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study. Ray WA; Chung CP; Murray KT; Malow BA; Daugherty JR; Stein CM PLoS Med; 2021 Jul; 18(7):e1003709. PubMed ID: 34264928 [TBL] [Abstract][Full Text] [Related]
26. Treatment of major depressive disorder in the Finnish general population. Hämäläinen J; Isometsä E; Sihvo S; Kiviruusu O; Pirkola S; Lönnqvist J Depress Anxiety; 2009; 26(11):1049-59. PubMed ID: 19123456 [TBL] [Abstract][Full Text] [Related]
27. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Asche CV; Joish VN; Camacho F; Drake CL Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321 [TBL] [Abstract][Full Text] [Related]
28. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Hausken AM; Furu K; Skurtveit S; Engeland A; Bramness JG Eur J Clin Pharmacol; 2009 Mar; 65(3):295-301. PubMed ID: 18810397 [TBL] [Abstract][Full Text] [Related]
29. Factors associated with long-term use of hypnotics among patients with chronic insomnia. Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018 [TBL] [Abstract][Full Text] [Related]
30. Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Siriwardena AN; Qureshi MZ; Dyas JV; Middleton H; Orner R Br J Gen Pract; 2008 Jun; 58(551):417-22. PubMed ID: 18505619 [TBL] [Abstract][Full Text] [Related]
31. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study. Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696 [TBL] [Abstract][Full Text] [Related]
32. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740 [TBL] [Abstract][Full Text] [Related]
33. Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan. Huang WF; Lai IC Drugs Aging; 2005; 22(11):957-65. PubMed ID: 16323972 [TBL] [Abstract][Full Text] [Related]
34. Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. Mendlewicz J World J Biol Psychiatry; 2009; 10(4):269-75. PubMed ID: 19921968 [TBL] [Abstract][Full Text] [Related]
35. Antidepressants for insomnia in adults. Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278 [TBL] [Abstract][Full Text] [Related]
38. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574 [TBL] [Abstract][Full Text] [Related]
39. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected]. Davies J; Rae TC; Montagu L Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996 [TBL] [Abstract][Full Text] [Related]
40. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]